[
  {
    "question": "Stroke patient and he has fever, Cardiac consultation showed pan systolic murmur; what is the treatment:",
    "option_a": "antiplatelets",
    "option_b": "Antibiotics",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This case represents an embolic stroke secondary to infective endocarditis. The combination of fever and a pansystolic murmur raises suspicion for an infectious process on the heart valves, which can lead to septic emboli causing stroke. In infective endocarditis, bacterial colonization of the heart valves produces vegetations that can break off and embolize to cerebral vessels. The inflammatory response and infection contribute to the clinical picture, and the vegetations are typically friable, leading to systemic embolization. Patients with infective endocarditis may present with stroke symptoms accompanied by systemic signs of infection (fever, malaise) and cardiac findings (e.g., a pansystolic murmur from regurgitant flow). The combination of these findings should prompt evaluation for endocarditis. The diagnostic approach includes obtaining multiple blood cultures and performing echocardiography (with transesophageal echocardiography being more sensitive) to identify vegetations. Differential diagnoses include non-infectious embolic strokes (e.g., cardioembolism from atrial fibrillation), which are less likely to present with fever. The current guidelines (AHA/ACC) recommend prompt initiation of empiric, then culture-guided, intravenous antibiotic therapy as the first line treatment in infective endocarditis. In cases complicated by large vegetations, heart failure, or uncontrolled infection, surgical intervention may be necessary. In pregnant and lactating patients, antibiotic selection should favor agents with proven safety profiles (e.g., penicillins and cephalosporins) while avoiding those known to carry teratogenic risks. Option A (antiplatelets) is insufficient because it does not address the underlying infection, whereas Option B (antibiotics) directly treats the bacterial cause of infective endocarditis, making it the correct choice. Unspecified options C and D add no therapeutic benefit in this scenario. 1) In any stroke patient with fever and a new murmur, always consider infective endocarditis. 2) Early detection and targeted antibiotic therapy are critical to reduce the risk of catastrophic embolic events. Recent research emphasizes early multimodal imaging and the use of advanced echocardiographic techniques to detect vegetations. Updated guidelines stress the importance of individualized antibiotic regimens based on microbial susceptibility, along with a multidisciplinary approach in managing complicated cases.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "60 years old came to ER with left side weakness and left decrease propioception and right tongue weakness; what is the artery involved?",
    "option_a": "Rigth Vert",
    "option_b": "Left Vert",
    "option_c": "Basilar",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This is a classic example of a crossed or alternating brainstem syndrome, where a lesion in the medulla produces ipsilateral cranial nerve deficits and contralateral motor and sensory deficits. Medial medullary syndrome (Dejerine syndrome) results from an infarct in the medial portion of the medulla. It affects the corticospinal tract and medial lemniscus, leading to contralateral weakness and loss of proprioception, as well as the hypoglossal nucleus or nerve, which causes tongue weakness on the same side as the lesion. The patient\u2019s presentation of left-sided body weakness and loss of proprioception with right-sided tongue weakness indicates a lesion in the right medial medulla. The tongue weakness (ipsilateral to the lesion) and contralateral limb deficits are hallmark features of medial medullary syndrome. Magnetic resonance imaging (MRI) of the brainstem is the investigation of choice. Vascular imaging with CT angiography or MR angiography helps in identifying the occluded vessel. Differential diagnoses include lateral medullary syndrome (Wallenberg syndrome) and pontine infarcts, but these present with different cranial nerve involvements. The standard management in acute stroke settings includes assessment for thrombolytic therapy eligibility. Secondary prevention strategies, such as antiplatelet agents and risk factor management (e.g., blood pressure control), are also essential. In pregnancy and lactation, thrombolytic agents and low-dose aspirin may be employed after careful risk assessment, as they are relatively safe when used appropriately. Option A (Right Vert) is correct because the right vertebral artery supplies the medial medulla where the lesion resides. Option B (Left Vert) would imply a lesion on the left medulla, which would lead to ipsilateral tongue weakness on the left, and Option C (Basilar) is more likely to affect different brainstem territories. 1) Alternating (crossed) neurological deficits are highly indicative of a brainstem stroke. 2) Medial medullary syndrome classically presents with contralateral hemiparesis and loss of proprioception alongside ipsilateral hypoglossal nerve dysfunction. Recent advances in neuroimaging have enhanced the localization of brainstem infarcts, and updated stroke management guidelines continue to prioritize rapid intervention with thrombolytic therapy where applicable.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Stroke patient has livedo reticularis what is the Dx?",
    "option_a": "Sneddon disease",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Sneddon disease (or syndrome) is defined by the association of livedo reticularis\u2014a characteristic net-like pattern on the skin\u2014with cerebrovascular events such as strokes. The underlying mechanism is believed to be a non-inflammatory thrombotic arteriopathy affecting medium-sized arteries, which may be related to the presence of antiphospholipid antibodies. This leads to occlusion of vessels in both the skin and the brain, resulting in the observed manifestations. Patients with Sneddon syndrome typically present with recurrent strokes or transient ischemic attacks in conjunction with the skin finding of livedo reticularis. Cognitive impairment and other systemic manifestations may also occur. Diagnosis involves clinical evaluation, skin examination, and supportive investigations such as antiphospholipid antibody testing and vascular imaging. Differential diagnoses include antiphospholipid syndrome, vasculitis, and systemic lupus erythematosus, which can present with overlapping features. Treatment centers on preventing further thromboembolic events, typically using antiplatelet therapy or anticoagulation depending on the presence of antiphospholipid antibodies. In pregnant women, low molecular weight heparin in combination with low-dose aspirin is often recommended to reduce the risk of thrombosis while maintaining safety for both mother and fetus. Option A (Sneddon disease) is the correct diagnosis given the presentation of livedo reticularis and stroke. Other options, if provided, do not typically manifest with this distinctive combination of clinical findings. 1) The presence of livedo reticularis in a stroke patient should prompt evaluation for Sneddon syndrome. 2) Consider testing for antiphospholipid antibodies when Sneddon syndrome is suspected, as it guides therapeutic decisions. Recent studies have further elucidated the role of immune-mediated thrombotic mechanisms in Sneddon syndrome, and evolving guidelines emphasize a tailored approach to anticoagulation versus antiplatelet therapy based on individual risk factors and antibody status.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "pt with stroke and had fibromuscular dysplasia, what next:",
    "option_a": "Renal Angio",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory arterial disease that commonly affects medium-sized arteries, most notably the renal and carotid arteries. FMD results from abnormal cellular proliferation and architectural distortion of the arterial wall, often producing a characteristic 'string-of-beads' appearance on angiography. When it involves the carotid or vertebral arteries, it can predispose to cerebrovascular events, whereas renal artery involvement may lead to renovascular hypertension. In a stroke patient found to have FMD, it is essential to evaluate for multisystem arterial involvement. The detection of FMD in the cerebrovascular circulation raises the possibility of concurrent renal artery disease, which has important implications for blood pressure management and overall vascular risk. Imaging studies such as computed tomography angiography (CTA), magnetic resonance angiography (MRA), or digital subtraction angiography (DSA) are used to diagnose FMD by visualizing the typical beading in affected arteries. Differential diagnoses include atherosclerotic disease, vasculitis, and arterial dissection. Management involves a comprehensive vascular evaluation. For patients with significant renal involvement, percutaneous transluminal angioplasty may be indicated to manage renovascular hypertension. Stroke management follows standard protocols including antiplatelet therapy and risk factor modification. In pregnant or lactating patients, blood pressure control is critical, and interventions such as angioplasty are considered only if clearly indicated, with careful minimization of radiation exposure. Option A (Renal Angio) is correct because once FMD is identified in a stroke patient, screening the renal arteries for involvement is essential for complete management. Other options would not address the need for a full vascular workup in FMD. 1) FMD is more common in young to middle-aged women and often involves multiple vascular territories. 2) Renal artery involvement in FMD can lead to secondary hypertension, necessitating early detection and appropriate intervention. Recent guidelines support the use of non-invasive angiographic techniques for diagnosing FMD and emphasize a multidisciplinary approach. Research continues to refine risk stratification and individualized treatment strategies, particularly concerning endovascular versus medical management.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "MRI with dissection, what to do:",
    "option_a": "Medical Therapy",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "The key concept is recognizing that an arterial dissection identified on MRI\u2014typically a cervical (carotid or vertebral) artery dissection\u2014is primarily managed medically. Dissections occur when there is a tear in the artery\u2019s intima allowing blood to enter the vessel wall, and this can lead to luminal stenosis, thrombus formation, and embolic stroke. The appropriate initial step is to institute antithrombotic therapy (antiplatelet or anticoagulation), which is encompassed under the term 'Medical Therapy'. An arterial dissection involves an intimal tear that permits blood to dissect into the media layer, creating a false lumen accompanied by an intramural hematoma. This process can cause vessel narrowing or occlusion and may predispose to thrombus formation with subsequent embolization, which is the primary mechanism for ischemic stroke in these patients. Patients with cervical artery dissections may present with unilateral neck pain, headache (often localized), and in carotid dissections, signs such as partial Horner syndrome. Neurologic deficits may occur if the dissection results in compromised cerebral blood flow or embolic stroke. Prompt diagnosis via imaging (such as MRI/MRA) is crucial for initiating treatment. When clinical evaluation suggests an arterial dissection, MRI (along with MRA/CTA) is used to identify features such as an intramural hematoma and double lumen. Differential diagnoses include atherosclerotic vascular disease or vasculitis; however, the imaging characteristics (e.g., crescent-shaped hyperintensity on fat-suppressed sequences) aid in distinguishing a dissection from other vascular pathologies. The current guidelines (including recommendations from the AHA/ASA and evidence from the CADISS trial) support the use of medical management with antithrombotic therapy as the first-line treatment. This may be achieved with either anticoagulants (such as heparin transitioning to warfarin or direct oral anticoagulants) or antiplatelet agents (such as aspirin). In pregnancy, LMWH is preferred over warfarin due to teratogenic risks; low-dose aspirin is also considered safe. During lactation, both LMWH and low-dose aspirin are generally acceptable. Surgical or endovascular interventions are reserved for patients with progression or complications refractory to medical management. The provided answer option, 'Medical Therapy', correctly encompasses the standard initial treatment for a cervical artery dissection. Other potential options (e.g., surgical intervention or conservative observational management without antithrombotic therapy) are less appropriate in the absence of contraindications or complicating factors. Thus, the marked answer A is correct. \u2022 Early recognition is critical in managing cervical artery dissection to prevent stroke. \n\u2022 Both antiplatelet and anticoagulation strategies have demonstrated similar efficacy; selection should be individualized based on patient factors and contraindications. \n\u2022 In pregnancy, consider LMWH and low-dose aspirin as safe options. \n\u2022 Follow-up imaging is important to assess healing and rule out complications such as pseudoaneurysm formation. Recent evidence from the CADISS trial has shown no significant difference in stroke prevention between anticoagulant and antiplatelet therapies for cervical artery dissections. Updated guidelines advocate for a medical management approach initially, with adjustments based on patient-specific factors including pregnancy and lactation where LMWH and aspirin are favored due to their safety profiles.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "73 years old female patient presented with decrease LOC showing hemorrhage with fluid level:",
    "option_a": "Amyloid",
    "option_b": "CVT",
    "option_c": "Anticoagulation use",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This case describes an elderly patient (73 years old) with decreased level of consciousness and imaging showing a hemorrhage with a fluid level. A fluid\u2013fluid level within a hemorrhage is a radiologic sign often associated with coagulopathy or the effects of anticoagulation, where the blood fails to clot uniformly, leading to layering of blood components. Although lobar hemorrhages in the elderly can also be due to cerebral amyloid angiopathy, the presence of a fluid level is more characteristic of bleeding in the setting of anticoagulant use. In patients on anticoagulant therapy (e.g., warfarin or direct oral anticoagulants), the normal clotting cascade is impaired. This leads to less effective clot formation and allows blood to remain in a liquid state for longer periods. Consequently, red blood cells may settle out, creating a visible fluid\u2013fluid level on imaging studies. This phenomenon is less typical in conditions like cerebral amyloid angiopathy or hemorrhagic venous infarctions seen in CVT. Elderly patients are often on anticoagulant therapy for conditions such as atrial fibrillation, mechanical heart valves, or a history of thromboembolism. In such patients, even minor head trauma or spontaneous bleeding can lead to significant intracranial hemorrhage. Decreased level of consciousness is a common manifestation, and the imaging finding of a fluid level within the hemorrhage further supports a coagulopathy-related bleed. When evaluating an intracranial hemorrhage in an elderly patient, it is essential to review the medication history (especially anticoagulant use), blood coagulation profiles, and correlate clinical symptoms with imaging findings. Differential diagnoses include: 1) Cerebral amyloid angiopathy, which typically causes lobar hemorrhages but without a distinct fluid level; 2) Cerebral venous thrombosis (CVT), which may lead to hemorrhagic infarcts but is less likely in this age group and with this imaging characteristic; 3) Anticoagulation-induced hemorrhage, which is strongly suggested by the presence of a fluid level. Management of anticoagulation-induced intracranial hemorrhage involves immediate stabilization of the patient, blood pressure control, and reversal of the anticoagulation. This might include the administration of vitamin K and prothrombin complex concentrate for warfarin-related bleed or specific reversal agents (e.g., idarucizumab for dabigatran, andexanet alfa for factor Xa inhibitors) when indicated. In pregnant or lactating patients (though not applicable in this 73-year-old case), management decisions would consider the safety of reversal agents; current guidelines recommend using agents with established safety profiles in pregnancy when reversal of anticoagulation is needed, with multidisciplinary consultation involving neurology, obstetrics, and hematology. Option A (Amyloid) is less likely because while cerebral amyloid angiopathy causes lobar hemorrhage, it does not typically produce a fluid\u2013fluid level. Option B (CVT) can lead to hemorrhagic infarcts but is not commonly associated with a fluid level and is more frequent in younger individuals. Option D is absent. Therefore, option C (Anticoagulation use) is the most consistent with the clinical and radiologic findings described. \u2022 A fluid\u2013fluid level in an intracranial hemorrhage should prompt evaluation for coagulopathy or anticoagulation use. \u2022 A thorough medication history is critical in elderly patients presenting with hemorrhage. \u2022 Reversal of anticoagulation is a key step in management to prevent hemorrhage expansion. Recent guidelines emphasize the importance of early recognition and reversal of anticoagulation in the setting of intracranial hemorrhage to reduce morbidity and mortality. Studies support the use of rapid reversal agents and multidisciplinary approaches for optimal outcomes. Although cerebral amyloid angiopathy is a common cause of lobar hemorrhages in the elderly, the imaging finding of a fluid level is most consistent with anticoagulant-associated bleeding, which is supported by current clinical and radiographic evidence.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "What is the artey?",
    "option_a": "mca",
    "option_b": "pca",
    "option_c": "ant choroidal artery",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question appears to assess knowledge of cerebral vascular anatomy. The options reference major cerebral arteries: the middle cerebral artery (MCA), posterior cerebral artery (PCA), and the anterior choroidal artery. The anterior choroidal artery is a smaller, but clinically important vessel that typically arises from the internal carotid artery. It supplies critical regions such as portions of the internal capsule, optic tract, and parts of the choroid plexus of the lateral ventricle. Occlusion or infarction in the territory of the anterior choroidal artery can produce the classic anterior choroidal syndrome, which may result in contralateral hemiparesis, hemisensory deficits, and homonymous hemianopia. Its small size and the fact that it supplies deep brain structures underscore the clinical relevance when vascular compromise occurs. Clinically, patients with an infarct in the anterior choroidal artery territory may present with a combination of motor, sensory, and visual deficits. Recognizing the distribution of neurological deficits can help distinguish strokes in this territory from those involving the MCA (which usually involves lateral cortical areas) or PCA (which often present with primary visual field deficits without the same degree of motor involvement). In practice, neuroimaging such as CT angiography or MR angiography is used to delineate the vascular territories and identify the culprit vessel. The differential diagnosis involves distinguishing between larger vessel strokes (MCA or PCA territory) and smaller deep infarcts. In a stroke setting, clinical findings supported by imaging can lead to targeted management. Management of an infarct in the anterior choroidal artery territory follows general ischemic stroke guidelines, including rapid revascularization therapy (e.g., IV thrombolysis if within therapeutic window) and secondary prevention (antiplatelet therapy, blood pressure control, and management of risk factors). In pregnancy, thrombolytic therapy (such as IV alteplase) can be considered after a careful risk-benefit analysis, and imaging modalities are selected to minimize fetal exposure. For lactating patients, standard stroke treatments are generally continued with counseling regarding medication safety during lactation. Option A (MCA) and Option B (PCA) both represent major cerebral arteries with distinct territorial supplies. The middle cerebral artery supplies large portions of the lateral cerebral cortex, whereas the posterior cerebral artery primarily supplies the occipital lobes. The anterior choroidal artery, Option C, is a small but critical branch commonly arising from the internal carotid artery, and it has a well-defined territory that, when infarcted, produces a distinct clinical picture. The marked answer, Option C, is the appropriate and most specific answer given the likely intent of the question. \u2022 The anterior choroidal artery supplies key deep brain structures including portions of the internal capsule and the optic tract.  \u2022 Infarcts in its territory may cause a combination of motor, sensory, and visual deficits (anterior choroidal artery syndrome).  \u2022 Timely identification of the involved artery via imaging is critical for rapid intervention.  \u2022 In pregnant or lactating patients, modifications in imaging technique and therapy (e.g., thrombolytics) need to be considered according to current guidelines. Recent stroke management guidelines emphasize rapid identification of the vascular occlusion and tailored reperfusion strategies. Advances in imaging have allowed more precise localization of infarcts even in small arterial territories such as the anterior choroidal artery. Moreover, evidence supports that standard stroke treatments can be safely and effectively modified for use in pregnant and lactating patients, with careful monitoring and risk assessment.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "What yoi will do?",
    "option_a": "Shunt",
    "option_b": "anticoagulant",
    "option_c": "give",
    "option_d": "give LMWH",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "In neurology and neurosurgery, a shunt procedure is employed to divert cerebrospinal fluid (CSF) and thereby relieve the signs and symptoms of hydrocephalus. Hydrocephalus may be obstructive (non-communicating) or communicating, and when medical management fails or is not indicated, surgical CSF diversion via shunting (typically a ventriculoperitoneal shunt) is the definitive treatment. Hydrocephalus results from an imbalance between CSF production and absorption or from an obstruction of CSF flow. This leads to an accumulation of CSF within the ventricular system, causing increased intracranial pressure. Over time, this pressure can compress brain tissue and lead to neurological deficits. The shunt bypasses the obstructed flow, allowing CSF to be diverted from the ventricles to another body cavity (usually the peritoneal cavity) where it can be absorbed. Patients with hydrocephalus may present with symptoms such as headache, nausea, vomiting, altered mental status, gait disturbances, and in some cases cognitive impairment. In conditions like normal pressure hydrocephalus (NPH), the classic clinical triad includes gait apraxia, dementia, and urinary incontinence. The decision to place a shunt is based on clinical findings as well as radiologic evidence of ventriculomegaly. Diagnosis requires neuroimaging, usually with CT or MRI. These studies help to confirm ventriculomegaly and to differentiate between communicating and non\u2010communicating causes of hydrocephalus. A lumbar puncture (after imaging rules out mass lesions) may also be used diagnostically especially in NPH where a large volume tap test can predict shunting success. The standard management of symptomatic hydrocephalus is CSF diversion by shunt placement. Current guidelines suggest that shunting is indicated in patients with confirmed hydrocephalus who have corresponding clinical symptoms. In pregnant patients, the decision to intervene surgically is based on symptom severity and risks. While the procedure itself carries risks inherent to surgery and anesthesia, multidisciplinary planning can minimize fetal risk. For lactating patients, shunt surgery is also considered safe, although supportive care and coordination with obstetrics is advisable. Option A (Shunt) is the only answer that corresponds to a definitive treatment in a scenario that implies a CSF diversion need. Options B (anticoagulant) and D (give LMWH) are relevant for conditions like cerebral venous sinus thrombosis and are not indicated in hydrocephalus unless there is an overlapping thromboembolic event. Option C ('give') is incomplete and non-specific. Given the context and the management strategy for hydrocephalus, the shunt option is the most appropriate. \u2022 Always correlate clinical symptoms with imaging findings to confirm the diagnosis of hydrocephalus before proceeding with shunt placement. \u2022 In cases of ambiguous neurological presentations, distinguishing between vascular (e.g., CVT requiring anticoagulation) and CSF flow disorders (requiring shunting) is key. \u2022 In special populations like pregnant or lactating women, multidisciplinary care ensures that both maternal and fetal/neonatal risks are minimized. Recent guidelines and studies continue to endorse CSF shunting (particularly ventriculoperitoneal shunting) as the gold standard for managing symptomatic hydrocephalus. Surgical techniques and postoperative care protocols have improved, reducing complications. In clinical practice, careful selection and preoperative testing (sometimes including a lumbar drain trial) help improve outcomes.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "What is the mechanism?",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "T",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question is centered on identifying the underlying mechanism responsible for a hemorrhagic event. It requires distinguishing between structural causes (such as hypertension-induced vessel changes or aneurysmal rupture) and systemic causes (like coagulopathy) that affect the clotting cascade. In this scenario, the key is recognizing that an impaired coagulation mechanism directly predisposes to bleeding. Coagulopathies impair the normal clotting cascade\u2014whether due to anticoagulant medication, liver dysfunction, or congenital disorders\u2014resulting in an inability to form stable fibrin clots. Unlike hemorrhages secondary to chronic hypertension (which result from long-term vascular remodeling and are typically seen in deep brain structures) or aneurysms (which usually cause sudden subarachnoid bleeding), coagulopathy-associated hemorrhages stem from a systemic deficiency in clot formation leading to spontaneous bleeding even without pre-existing vascular lesions. Patients with coagulopathy\u2010induced hemorrhages may present with intracerebral bleeding that appears in atypical locations compared to the classic deep brain regions seen in hypertensive hemorrhage. Laboratory tests (such as PT, INR, and PTT) help confirm the diagnosis. Clinically, the lack of a history of severe hypertension or aneurysmal symptoms combined with abnormal coagulation profiles should guide clinicians toward this diagnosis. The diagnostic workup includes neuroimaging (CT/MRI) to determine the location and pattern of hemorrhage, along with coagulation studies to assess clotting function. Differential diagnoses include: 1) Hypertensive hemorrhage (typically in the basal ganglia, thalamus, or cerebellum) characterized by a history of chronic hypertension; 2) Aneurysmal rupture, which classically causes subarachnoid hemorrhage; and 3) Other vascular malformations that usually have distinct imaging patterns. Management focuses on rapid stabilization and reversal of the coagulopathic state. First-line interventions include administration of vitamin K, fresh frozen plasma, or prothrombin complex concentrates based on the underlying cause. In cases where anticoagulant medications are involved, specific reversal agents (for example, idarucizumab for dabigatran) may be required. In pregnant or lactating patients, the decision to reverse a coagulopathy must balance maternal risks with fetal considerations; many reversal agents have been studied in these populations, and a multidisciplinary approach (involving obstetrics and hematology) is advised. \u2022 Option 1 (Hypertension): Incorrect because while chronic HTN can cause hemorrhage, it typically does so through long-term vascular changes rather than through an acute impairment of coagulation. \u2022 Option 2 (Coagulopathy): Correct since a systemic clotting defect disrupts normal hemostasis and predisposes to bleeding. \u2022 Option 3 (Aneurysm): Incorrect as aneurysms lead to hemorrhage via focal arterial dilation and rupture, usually resulting in subarachnoid hemorrhage. 1. In the absence of typical risk factors like chronic hypertension, always consider a coagulopathy when evaluating spontaneous intracranial hemorrhage. 2. Rapid identification and reversal of a coagulation defect can prevent further bleeding and improve outcomes. Recent literature emphasizes the importance of differentiating hemorrhage etiologies because treatment differs markedly. Advances in specific reversal agents have improved outcomes in coagulopathy\u2010induced hemorrhages. Current guidelines stress the prompt correction of coagulation abnormalities, particularly in patients receiving anticoagulants.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "82 years old male pt came within 3 hrs and have no contraindication for tpa and ct attached with early signe of stroke but infarction not established what you will give",
    "option_a": "aspirin",
    "option_b": "plavix",
    "option_c": "tpa",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question tests the acute management of ischemic stroke within the therapeutic time window. The central concept is that timely administration of a thrombolytic agent, such as tissue plasminogen activator (tPA), significantly improves neurological outcomes by dissolving the clot obstructing cerebral blood flow. Acute ischemic stroke is caused by an arterial occlusion that leads to cerebral ischemia. tPA acts by converting plasminogen to plasmin, which then degrades fibrin, effectively lysing the clot and restoring blood flow to the affected brain region. This reperfusion of the penumbra limits infarct size. In the clinical scenario described, the 82-year-old male presents within a crucial 3-hour window, where early CT imaging reveals subtle signs of ischemia without established infarction, making him an ideal candidate for tPA. Despite advanced age, the eligibility criteria for tPA are met, reflecting current practices where age alone is not a contraindication. Diagnosis is confirmed with a non-contrast CT scan to rule out hemorrhage and ascertain the absence of significant infarction. Differential considerations include transient ischemic attack (TIA) and hemorrhagic stroke, but rapid imaging and clinical examination help exclude these possibilities. First-line treatment for eligible patients with acute ischemic stroke is IV tPA administered within 3 to 4.5 hours of symptom onset. If patients present outside this window or have contraindications, alternative interventions such as mechanical thrombectomy may be considered. For pregnant patients facing stroke, tPA can be administered after careful risk-benefit analysis and consultation with obstetric specialists, as improved maternal outcomes often translate into better fetal outcomes. In lactating women, tPA administration is generally considered safe, but appropriate counseling is recommended. \u2022 Option A (Aspirin) and Option B (Plavix): These antiplatelet agents are used for long-term secondary prevention, not for acute thrombolysis. \u2022 Option C (tPA): Correct, as it addresses the need for prompt thrombolysis in acute ischemic stroke. \u2022 Option D: Not provided and unnecessary in this context. 1. The mantra 'time is brain' underlines the importance of rapid thrombolytic therapy in acute stroke management. 2. Advanced age should not preclude the use of tPA if other eligibility criteria are satisfied. Recent studies and stroke guidelines (e.g., those from the American Heart Association) reinforce the use of IV tPA in eligible patients within the tight treatment window. Continuous updates in stroke care protocols stress rapid imaging and swift decision-making, and recent research supports the safety and effectiveness of tPA even in older populations.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Rt small thalamic hemorrhage since one day, BP normal, pic attached no hydro or ventricular extension what to do next",
    "option_a": "(Prophylaxis LMWH): Correct because it reduces the risk of thromboembolic complications in a patient with a stable hemorrhage. \u2022 Option B (EVD): Incorrect, as external ventricular drainage is indicated in cases with hydrocephalus or significant intraventricular bleeding, which is not present in this patient.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question focuses on the management of a patient with a small intracerebral hemorrhage, specifically addressing the prevention of secondary thromboembolic complications. Once a hemorrhage is stable, prophylactic measures to minimize venous thromboembolism become paramount. A small thalamic hemorrhage, when stable and not complicated by hydrocephalus or ventricular extension, still puts the patient at risk for venous thromboembolism due to prolonged immobilization. Low Molecular Weight Heparin (LMWH) acts by inhibiting factor Xa (and to a lesser extent, thrombin), thereby reducing the risk of clot formation without significantly increasing the chance of rebleeding when administered at the correct time. In this case, the patient\u2019s blood pressure is normal and imaging confirms that the hemorrhage is confined to the thalamus with no evidence of mass effect or hydrocephalus. This scenario supports the initiation of prophylactic anticoagulation to prevent deep venous thrombosis (DVT) as part of secondary prevention. Neuroimaging helps assess the size and nature of the hemorrhage. Differential diagnoses might include hemorrhagic transformation of an ischemic stroke or a ruptured aneurysm; however, these alternatives are less likely given the imaging findings and absence of hydrocephalus. The first step involves ensuring hemodynamic stability and controlling blood pressure. If the hemorrhage is confirmed to be stable (typically after the first 24 hours), prophylactic LMWH is recommended to lower the risk of DVT. In special populations such as pregnant women, LMWH is generally considered safe (category B) with minimal placental transfer, and in lactating mothers, LMWH remains the preferred anticoagulant given its low risk of transmission through breast milk. \u2022 Option A (Prophylaxis LMWH): Correct because it reduces the risk of thromboembolic complications in a patient with a stable hemorrhage. \u2022 Option B (EVD): Incorrect, as external ventricular drainage is indicated in cases with hydrocephalus or significant intraventricular bleeding, which is not present in this patient. 1. In patients with intracerebral hemorrhage, the initiation of VTE prophylaxis should be timed appropriately (after 24 hours) to avoid rebleeding. 2. A stable, small hemorrhage without ventricular involvement allows for safe prophylactic anticoagulation. Latest guidelines from stroke and neurosurgical societies support early prophylactic anticoagulation in patients with stable intracerebral hemorrhage to prevent DVT. Recent studies continue to refine optimal timing and dosing strategies to maximize safety and efficacy while minimizing the risk of hematoma expansion.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Male with progressive myelopathy attached image clearly showing slow void, and long cord signal changes, dx",
    "option_a": "(DAVF): Correct, as the combination of progressive myelopathy and MRI findings with slow flow voids and elongated cord signal anomalies is classic for this diagnosis. Alternative options such as multiple sclerosis, transverse myelitis, or spinal tumors do not typically show the vascular flow voids on imaging.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question examines the identification of a spinal vascular malformation as the cause of progressive myelopathy. The key concept is understanding that chronic venous congestion due to abnormal arteriovenous shunting can lead to spinal cord dysfunction over time. Spinal dural arteriovenous fistula (DAVF) is characterized by an abnormal connection between a radiculomeningeal artery and a medullary vein. This shunt elevates venous pressure, leading to cord congestion and ischemia. The chronic venous hypertension results in progressive myelopathy due to a combination of cord edema and insufficient perfusion. Patients with DAVF typically present with slowly progressive symptoms such as lower extremity weakness, sensory changes, and sphincter dysfunction. The MRI findings of long-segment T2 hyperintensity with serpiginous flow voids strongly suggest the presence of dilated, abnormal vessels consistent with DAVF, correlating directly with the progressive clinical picture. The diagnostic strategy includes MRI which reveals both the cord signal changes and the characteristic flow voids of dilated vessels. Differential diagnoses include multiple sclerosis (often multifocal and ovoid lesions without abnormal flow voids), transverse myelitis (acute inflammatory process without dilated vessels), and spinal neoplasms (typically focal with mass effect rather than diffuse vascular changes). The first-line treatment for spinal DAVF is endovascular embolization, aiming to interrupt the abnormal shunt. When embolization is not feasible or is incomplete, surgical disconnection of the fistula is considered. In pregnant patients, management requires a multidisciplinary approach given the risks associated with radiation exposure and anesthesia; tailored intervention with minimized fluoroscopy time is advised. For lactating patients, similar considerations apply with close monitoring and counseling regarding procedural risks. \u2022 Option A (DAVF): Correct, as the combination of progressive myelopathy and MRI findings with slow flow voids and elongated cord signal anomalies is classic for this diagnosis. Alternative options such as multiple sclerosis, transverse myelitis, or spinal tumors do not typically show the vascular flow voids on imaging. 1. When evaluating progressive myelopathy, always inspect MRI images for abnormal flow voids which may indicate a DAVF. 2. Early recognition of spinal DAVF is critical to prevent irreversible spinal cord damage. Recent research and clinical guidelines emphasize the importance of prompt diagnosis and intervention in spinal DAVF. Newer endovascular techniques and surgical approaches have demonstrated improved outcomes, and current studies focus on optimizing the timing and method of intervention to maximize neurological recovery.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Male with renal impairment, stroke, angiokeratoma pic asking about enzyme supp",
    "option_a": "(alpha",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Fabry disease is an X\u2010linked lysosomal storage disorder caused by a deficiency in the enzyme alpha-galactosidase A. This deficiency leads to the accumulation of glycosphingolipids, particularly globotriaosylceramide (Gb3), in various cell types and tissues, including vascular endothelial cells, kidney, heart, and skin. The lack of functional alpha-galactosidase A results in progressive storage of Gb3 within lysosomes. This accumulation induces cellular damage, microvascular dysfunction, and inflammatory changes that contribute to end-organ damage such as renal impairment, cerebrovascular ischemia (stroke), and characteristic skin findings (angiokeratomas). In men especially, the classic phenotype can be severe, with early manifestations affecting multiple systems. Patients often present with a combination of symptoms including neuropathic pain, angiokeratomas (small, reddish-purple skin lesions), renal impairment, and an increased risk for cerebrovascular events. The concurrence of renal dysfunction, stroke, and skin lesions in a male patient is highly suggestive of Fabry disease. Diagnosis is confirmed by measuring alpha-galactosidase A activity in plasma or leukocytes and can be supported by genetic testing for mutations in the GLA gene. Differential diagnoses include other lysosomal storage disorders such as Gaucher disease (beta\u2010glucocerebrosidase deficiency) and Pompe disease (alpha\u2010glucosidase deficiency), which have distinct clinical and enzymatic profiles. The first-line treatment is enzyme replacement therapy (ERT) with recombinant alpha-galactosidase A, which helps reduce substrate accumulation and slow disease progression. Adjunctive management includes supportive interventions for renal, cardiac, and cerebrovascular complications. In pregnancy and lactation, treatment decisions must carefully balance maternal benefits against potential fetal risks, and multidisciplinary consultation is advised as current data on ERT during pregnancy remain limited. Option A (alpha-galactosidase, here noted as 'Galtcosidase') is correct since it directly addresses the enzyme deficiency in Fabry disease. Other enzymes listed, such as beta-glucocerebrosidase (associated with Gaucher disease), alpha-glucosidase (associated with Pompe disease), or galactocerebrosidase (associated with Krabbe disease), are unrelated to the pathogenesis of Fabry disease. 1. The triad of renal impairment, stroke, and angiokeratomas in a male patient should prompt consideration of Fabry disease. 2. Early initiation of ERT may attenuate long-term organ damage. 3. Enzyme activity assays coupled with genetic testing are crucial for a definitive diagnosis. Recent clinical studies underscore the benefits of early intervention with ERT in Fabry disease to delay progression of organ dysfunction. Current guidelines advocate for a multidisciplinary approach, with close attention to cardiac and renal monitoring, and emerging research continues to refine optimal dosing and treatment initiation timings.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario patient feeling unwell, then start seeing animals after which he had decreased LOC intubated, decerebrate posturing CT brain attached showed hyperdense basilar sign otherwise no clear ischemic changes what to do next",
    "option_a": "(CTA) is correct because CTA provides non",
    "option_b": "(EEG) is incorrect as it evaluates brain electrical activity and is not useful in diagnosing vascular occlusions.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Basilar artery occlusion is a serious form of ischemic stroke affecting the posterior circulation. The hyperdense basilar artery sign on non-contrast CT is a key radiological finding that raises suspicion for this condition. An occlusive thrombus or embolus within the basilar artery can lead to reduced blood flow to critical brainstem regions. The hyperdense appearance on CT reflects the clot\u2019s density relative to normal blood, while the resultant ischemia causes brainstem dysfunction, which may manifest as altered consciousness or abnormal posturing. In the described scenario, the patient\u2019s initial nonspecific symptoms rapidly progress to severe neurological compromise (decreased level of consciousness, decerebrate posturing) indicating brainstem involvement. The hyperdense basilar sign on CT strongly suggests a vascular occlusion requiring urgent further imaging and intervention. Following a non-contrast CT that reveals a hyperdense basilar artery, the next step is to perform CT angiography (CTA) to confirm the location and extent of the occlusion, assess collateral circulation, and guide reperfusion strategies. The differential includes non-ischemic causes of brainstem dysfunction (e.g., encephalopathy, metabolic disturbances) but these do not explain the hyperdense vascular sign. Management involves rapid reperfusion, which may include intravenous thrombolysis (if within the therapeutic window, usually 4.5 hours) and endovascular thrombectomy. Intensive care monitoring and supportive measures are essential. In pregnant patients, risk-benefit analysis regarding thrombolysis or endovascular interventions should be performed in conjunction with obstetrical consultation, as the safety profiles of these treatments during pregnancy require careful consideration. Option A (CTA) is correct because CTA provides non-invasive, rapid confirmation of vascular occlusion by visualizing the basilar artery. Option B (EEG) is incorrect as it evaluates brain electrical activity and is not useful in diagnosing vascular occlusions. 1. A hyperdense basilar artery sign on CT should prompt immediate vascular imaging with CTA. 2. Time is brain: rapid identification and treatment of basilar artery occlusion are crucial to prevent devastating brainstem infarction. 3. Endovascular therapy has become a key component in the management of large vessel occlusions. Recent guidelines and studies have reinforced the role of CTA in the acute stroke workup, with growing evidence supporting endovascular thrombectomy even in extended time windows for select patients. Current protocols emphasize rapid diagnosis and the integration of advanced neuroimaging to optimize outcomes.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "What is the mechanism?",
    "option_a": "tramatic haemorrage",
    "option_b": "ICh",
    "option_c": "lobar haemorrage",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Intracerebral hemorrhage (ICH) refers to bleeding within the brain tissue and is most commonly a spontaneous event due to hypertension, although other causes exist. Differentiating among traumatic hemorrhage, deep (hypertensive) ICH, and lobar hemorrhages is key in understanding the underlying pathology. Hypertensive ICH typically results from chronic hypertension causing degeneration of the small penetrating arteries (with Charcot-Bouchard microaneurysm formation), leading to rupture and bleeding into the brain parenchyma. In contrast, lobar hemorrhages often occur in the cerebral lobes and may be associated with cerebral amyloid angiopathy, particularly in the elderly, while traumatic hemorrhages result from injury. Clinical presentations of ICH vary but generally include a sudden onset of neurological deficits, headache, and altered consciousness. The location of the hemorrhage (deep versus lobar) can provide clues about the underlying etiology: deep ICH is commonly linked to hypertension, whereas lobar hemorrhages suggest alternative causes. Non-contrast CT is the first-line diagnostic tool to identify the location and extent of bleeding. History (including the presence or absence of trauma) and risk factors such as long-standing hypertension or amyloid angiopathy help differentiate the type of hemorrhage. Magnetic resonance imaging (MRI) may further characterize the hemorrhage and identify underlying lesions. Management of ICH includes aggressive blood pressure control, reversal of any coagulopathy, and supportive care in an intensive care setting. In cases of large hematomas or significant mass effect, surgical intervention may be considered. For pregnant or lactating patients, blood pressure targets remain similar; however, interventions must carefully weigh maternal neurological status against fetal risks, often necessitating multidisciplinary management. Option A (traumatic hemorrhage) is incorrect in a scenario without evidence of trauma. Option B (ICH) is correct because it aligns with the pathophysiology of spontaneous intracerebral hemorrhage typically seen in hypertensive patients. Option C (lobar hemorrhage) refers to a subtype generally associated with cerebral amyloid angiopathy and does not represent the general mechanism established for hypertensive ICH. 1. Hypertensive ICH most often involves deep brain structures such as the basal ganglia and thalamus. 2. Distinguishing between spontaneous and traumatic hemorrhage is critical and relies heavily on patient history and imaging findings. 3. Rapid blood pressure management is a cornerstone of ICH treatment to prevent hematoma expansion. Recent clinical trials have supported intensive blood pressure control as a means to limit hematoma growth and improve outcomes in ICH. Research continues into minimally invasive surgical approaches, and updated guidelines emphasize individualized care that considers both the size and location of the hemorrhage.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "What is the mechanism?",
    "option_a": "(Aneurysm rupture) is incorrect because the hemorrhage pattern in premesencephalic hemorrhage does not support an aneurysmal source. Option B (Atherosclerosis) is incorrect as it is associated with ischemic strokes rather than subarachnoid hemorrhage. Option C (Premesencephalic hemorrhage) is correct because it accurately describes the mechanism for this subtype of SAH. The previously marked answer (D) does not correspond to any of the relevant options provided.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Subarachnoid hemorrhage (SAH) can occur due to a variety of mechanisms. Premesencephalic (or perimesencephalic) hemorrhage is a subtype of non-aneurysmal SAH characterized by bleeding in the cisternal spaces around the midbrain with a relatively benign clinical course. Unlike aneurysmal SAH, which is typically due to aneurysm rupture and is associated with a high risk of rebleeding and vasospasm, premesencephalic hemorrhage is believed to result from venous or small arterial bleeding in the premesencephalic cisterns. It usually does not involve an aneurysm, and patients often experience a smoother recovery with fewer complications. Patients with premesencephalic hemorrhage tend to present with a sudden-onset headache that may be less severe than that associated with aneurysmal SAH. Neurological deficits are often minimal, and the clinical course is more benign. The limited blood spread on imaging distinguishes it from aneurysmal SAH. Initial evaluation with non-contrast CT typically shows blood localized around the midbrain without the extensive subarachnoid spread seen in aneurysm rupture. Vascular imaging (CTA, MRA, or digital subtraction angiography) is undertaken to rule out aneurysms. Differential diagnoses include aneurysmal SAH and other non-aneurysmal causes of SAH, which are differentiated based on the distribution of blood on imaging and clinical severity. Management is generally conservative, including bed rest, analgesia, and close neurological monitoring. Nimodipine is less frequently used because the risk of vasospasm is much lower compared to aneurysmal SAH. In pregnant or lactating women, conservative management is especially preferred unless there is evidence of complications, with decisions being made in consultation with neurology and maternal-fetal medicine specialists. Option A (Aneurysm rupture) is incorrect because the hemorrhage pattern in premesencephalic hemorrhage does not support an aneurysmal source. Option B (Atherosclerosis) is incorrect as it is associated with ischemic strokes rather than subarachnoid hemorrhage. Option C (Premesencephalic hemorrhage) is correct because it accurately describes the mechanism for this subtype of SAH. The previously marked answer (D) does not correspond to any of the relevant options provided. 1. Premesencephalic hemorrhage has a benign course compared to aneurysmal SAH, with lower rates of vasospasm and rebleeding. 2. The localization of bleeding on CT is a critical clue in differentiating premesencephalic hemorrhage from aneurysmal SAH. 3. Vascular imaging must be performed to exclude the presence of an aneurysm, even when a premesencephalic pattern is suspected. Recent studies have confirmed that patients with premesencephalic hemorrhage generally have excellent outcomes and benefit from conservative management. Updated guidelines recommend distinguishing this entity from aneurysmal SAH to ensure appropriate, less invasive management strategies are applied.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "sickler pt come with stroke work up done and found to have multiple stenosis in AcA and McA. Ehat is the method of prevention?",
    "option_a": "aspirin",
    "option_b": "plavix",
    "option_c": "chronic transfusion",
    "option_d": "dual antiplate",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Sickle cell disease (SCD) predisposes patients to cerebrovascular complications because of the abnormal hemoglobin (HbS) that can polymerize under low oxygen conditions. This leads to recurrent vaso\u2010occlusion and chronic vascular injury. In the context of stroke prevention, reducing the proportion of sickled cells is paramount. In SCD, red blood cells containing HbS undergo polymerization during deoxygenation, leading to deformation and aggregation. The recurring infarctions and subsequent vessel wall injury result in stenosis in critical cerebral arteries such as the anterior cerebral (AcA) and middle cerebral (McA) arteries. Chronic transfusion therapy works by diluting the concentration of HbS, thus lowering the risk of further vaso\u2010occlusive events and progression of vasculopathy. Patients with SCD frequently develop cerebrovascular disease, which may manifest as stroke or transient ischemic attacks, particularly when arterial stenosis is present. A history of abnormal transcranial Doppler studies or a prior stroke indicates the need for aggressive measures to prevent recurrence. The workup includes transcranial Doppler ultrasound (especially in the pediatric population) to screen for increased velocities, brain MRI to delineate infarcted areas, and vascular imaging (CTA/MRA) to assess the degree and location of arterial stenoses. Differential diagnoses include other causes of stroke such as cardioembolic events or conventional atherosclerosis, but the presence of SCD directs the etiology to vaso\u2010occlusion mechanisms. First\u2010line prevention for recurrent strokes in SCD is chronic transfusion therapy aimed at maintaining the percentage of HbS below a target threshold (often <30%). In addition, hydroxyurea is sometimes used in select patients to reduce vaso\u2010occlusive crises. For pregnant or lactating patients with SCD, transfusion protocols are modified with close monitoring to avoid iron overload and alloimmunization, while hydroxyurea is generally avoided during pregnancy. \u2022 Option A (aspirin): Although antiplatelet agents are standard in general stroke prevention, they do not address the underlying sickling process in SCD. \n\u2022 Option B (plavix): Similarly, clopidogrel is not indicated as a primary preventive measure in SCD-related strokes. \n\u2022 Option C (chronic transfusion): This is the evidence-based approach for secondary prevention in SCD patients with stroke, addressing the fundamental abnormality by reducing HbS levels. \n\u2022 Option D (dual antiplatelet): Dual antiplatelet therapy is used in atherosclerotic disease but is not the standard measure for stroke prevention in SCD. \u2022 Chronic transfusion therapy has been shown to reduce recurrent stroke risk in patients with SCD by decreasing the proportion of HbS. \n\u2022 Regular transcranial Doppler screening is a key preventive strategy in pediatric SCD populations. Recent trials and guidelines (for example, those emerging from the STOP and TWiTCH studies) have reinforced the use of chronic transfusion therapy as the cornerstone for preventing recurrent stroke events in patients with SCD.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "What you will do:",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Large vessel atherosclerotic disease that leads to stroke is initially managed with optimized medical therapy rather than immediate intervention. The focus is on reducing the risk factors that contribute to plaque formation and thrombosis. Atherosclerotic plaques develop in the carotid or other large cerebral vessels, which can lead to significant stenosis and increased risk of thromboembolic events. The systemic inflammatory process and endothelial dysfunction promote plaque instability. Medical therapy aims to stabilize plaques, control dyslipidemia, and reduce platelet aggregation. In patients with symptomatic or high-grade carotid stenosis, the choice between medical management, endarterectomy, or stenting depends on the degree of stenosis, symptom status, and individual patient risk factors. Often, patients present with minor strokes or transient ischemic attacks and require risk factor modification as a first-line approach. Diagnosis is supported by duplex ultrasound, CTA, or MRA to quantify the degree of stenosis. Differential diagnoses include cardioembolism and small vessel disease, which are managed differently. \u2022 First-line management is optimized medical therapy, including antiplatelet agents (like aspirin), high-intensity statin therapy, and strict control of blood pressure and diabetes. \n\u2022 Carotid endarterectomy is reserved for symptomatic patients with high-grade stenosis (commonly >70%). \n\u2022 Carotid stenting is considered in patients who are not candidates for surgery. \nPregnancy and lactation: In pregnant patients, medication choices must consider fetal safety; low-dose aspirin may be continued, but statins are contraindicated. A tailored therapeutic plan is necessary. \u2022 Option 1 (Angioplasty alone): Not adequate as a sole therapy because angioplasty without stenting can lead to vessel recoil and restenosis. \n\u2022 Option 2 (Stent): Carotid stenting has a higher periprocedural stroke risk and is generally reserved for patients with contraindications to surgery. \n\u2022 Option 3 (Endarterectomy): While effective, it is not universally applied and is appropriate mainly in selected high-grade stenosed, symptomatic patients. \n\u2022 Option 4 (Medical therapy): This is the appropriate first-line intervention, focusing on aggressive risk factor modification and pharmacologic therapy. \u2022 Optimized medical therapy remains the cornerstone for initial management of most patients with large vessel cerebrovascular stenosis. \n\u2022 Revascularization techniques are specifically reserved for cases where the benefit outweighs the risks based on the degree of stenosis and symptomatology. Recent studies, including the CREST trial and evolving AHA/ASA guidelines, underscore the importance of initiating intensive medical therapy as the primary approach for stroke prevention in patients with carotid stenosis, with revascularization considered only in select high-risk patient populations.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Stroke all stroke workups mentioned except CTA asked what to do next",
    "option_a": "(CTA): Correct because it provides rapid, comprehensive vascular imaging necessary for acute stroke management. \n\u2022 Option B: Does not offer the comprehensive vascular assessment needed for immediate management decisions. Other non",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "In the workup of acute stroke, after initial non-contrast imaging to rule out hemorrhage, rapid vascular imaging is critical to identify occlusions or stenoses that can guide acute therapeutic interventions. Cerebrovascular occlusions, particularly in large vessel strokes, require quick identification to determine candidacy for reperfusion therapies. Computed tomography angiography (CTA) provides detailed images of the cerebral vasculature, allowing for identification of vessel occlusions and stenosis patterns. In an acute stroke setting, time is brain \u2013 rapid identification of a large vessel occlusion can lead to timely decisions regarding thrombolysis or thrombectomy, which are essential for improving outcomes. The usual diagnostic workflow in suspected acute ischemic stroke includes an initial non-contrast CT (NCCT) to exclude hemorrhage, followed by CTA to evaluate the arterial system. Differential diagnoses might include plain CT (which cannot assess vessel patency adequately), MRI/MRA (which is accurate but may not be as rapidly accessible), or carotid Doppler (limited to extracranial evaluation). Current guidelines (such as those from the AHA/ASA) recommend that after an NCCT, CTA should be performed immediately to assess for large vessel occlusion, facilitating decision making regarding thrombolytic therapy or endovascular intervention. In pregnancy, non-contrast imaging is preferred initially to reduce radiation, but if CTA is necessary, precautions (such as abdominal shielding) should be taken. In lactating patients, CTA can be performed as the risk is minimal. \u2022 Option A (CTA): Correct because it provides rapid, comprehensive vascular imaging necessary for acute stroke management. \n\u2022 Option B: Does not offer the comprehensive vascular assessment needed for immediate management decisions. Other non-contrast studies or limited vascular studies are insufficient when CTA data is critical for reperfusion decision-making. \u2022 CTA is the modality of choice to rapidly evaluate the cerebral vasculature after initial stroke imaging. \n\u2022 Quick delineation of vascular status is essential for determining eligibility for advanced reperfusion therapies. Recent evidence and updated AHA/ASA guidelines continue to support the role of CTA as a critical next step in the imaging algorithm for acute ischemic stroke, affirming its place in current stroke protocols.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with ESRD Scenario with pic showing rt superficial borderzone infarction at MCA/ACA territory asking about next investigation",
    "option_a": "(Brain CT angiography alone): Although it provides good intracranial detail, it is incomplete without neck imaging to evaluate the carotid arteries. \n\u2022 Option B (Conventional angiography): While being the gold standard, it is invasive and carries higher risks, especially in ESRD patients. \n\u2022 Option C: Implied to represent a comprehensive CTA (including both brain and neck vessels), which is the most appropriate next investigation given its noninvasive nature and ability to assess the entire cerebrovascular system.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Watershed (borderzone) infarctions typically occur in areas between major cerebral arterial territories and are often due to hemodynamic compromise rather than embolic occlusion. In patients with conditions such as ESRD, who have a higher burden of atherosclerosis, the evaluation of both intracranial and extracranial vessels is crucial. Borderzone infarcts result from hypoperfusion, where the distal territories of the cerebral arteries (such as the MCA and ACA territories) are inadequately supplied. This commonly occurs in the presence of significant arterial stenosis, especially at the carotid bifurcation, leading to a reduced perfusion pressure in these watershed regions. In patients with ESRD, the risk of atherosclerotic disease is heightened. A superficial borderzone infarct as seen on imaging should prompt consideration of a hemodynamic mechanism, and a comprehensive vascular evaluation is necessary to determine the extent and location of any stenotic lesions. The optimal evaluation includes a CT angiography (CTA) that encompasses both the intracranial vessels and the cervical (extracranial) carotid arteries. Differential diagnoses include relying solely on brain CTA (which may miss extracranial pathology) or invasive conventional angiography, which carries unnecessary risk as a first-line investigation. For patients with suspected hemodynamic compromise from carotid stenosis, a comprehensive, noninvasive vascular imaging study (CTA of both brain and neck) is the first investigation of choice. In patients with ESRD, while the use of contrast is a consideration, the patient\u2019s renal status (often already on dialysis) modifies the risk-benefit ratio. In pregnant or lactating patients, contrast studies are approached cautiously with appropriate shielding and timing, though ESRD typically precludes pregnancy. \u2022 Option A (Brain CT angiography alone): Although it provides good intracranial detail, it is incomplete without neck imaging to evaluate the carotid arteries. \n\u2022 Option B (Conventional angiography): While being the gold standard, it is invasive and carries higher risks, especially in ESRD patients. \n\u2022 Option C: Implied to represent a comprehensive CTA (including both brain and neck vessels), which is the most appropriate next investigation given its noninvasive nature and ability to assess the entire cerebrovascular system. \u2022 In borderzone infarctions, always ensure that the vascular imaging covers both intracranial and extracranial territories. \n\u2022 ESRD patients are at increased risk for significant atherosclerotic disease and warrant comprehensive evaluation despite concerns regarding contrast media. The latest stroke imaging protocols and guidelines emphasize the value of a comprehensive CTA that includes neck imaging to assess for extracranial carotid disease, particularly in cases of watershed infarcts. This approach minimizes risk while providing detailed vascular mapping to guide further management.",
    "exam_year": "2022",
    "exam_type": "Part II"
  }
]